Research Content Services

customer support

JMIR Publications’ JMIRx Med accepted for indexing in PubMed and PubMed Central -

JMIR Publications has announced that its first-of-its-kind overlay journal, JMIRx Med, has been accepted for indexing in PubMed Central (PMC) and PubMed.

As the first overlay journal in PMC and PubMed, JMIRx Med becomes the standard-bearer of this important innovation in scholarly publishing. Editors of overlay journals select content already posted on preprint servers such as medRxiv and bioRxiv. They then select manuscripts that match the scope and quality parameters of their publications and offer authors a rapid peer review and possible publication of their preprints, coupled with all the traditional elements of a journal publication. JMIRx Med enters the ranks of PubMed-ranked scientific publications following the US National Library of Medicine’s (NLM’s) rigorous evaluation criteria. Papers published in JMIRx Med will be in PubMed by mid-summer 2022, after legacy files are prepared and deposited.

Dr. Gunther Eysenbach, CEO of JMIR Publications originally announced the new journal in 2019. Shortly after JMIRx Med was launched, the NLM also announced the National Institutes of Health (NIH) Preprint Pilot, where NIH-funded preprints are indexed in PMC and PubMed. JMIRx Med is part of a new, revisionist publishing model conceptualized by Eysenbach, called Plan P—a progressive framework and platform for institutions and funders to promote open science.

Overlay journals like JMIRx Med help authors in their publication endeavors by allowing them to bypass the step of separate submission to journals. Instead, editors and community reviewers get alerted about the papers they want to publish and extend conditional offers of publication to interesting articles published on preprint servers. Authors can also self-nominate their existing preprints for publication (which is equivalent to a traditional journal submission), using a very simple submission form that points to the preprint.

Speaking about overlay journals at the 2021 Council of Science Editors annual meeting, Eysenbach stressed that JMIRx Med will not be publishing unsolicited peer reviews of manuscripts and will also work with the authors to improve their preprints and publish final versions of record. JMIRx Med solicits comments on preprints, allows authors to respond to scholarly critique, and when finalized, publishes the fully revised manuscript as the citable version of record.

Click here to read the original press release.

STORY TOOLS

  • |
  • |

sponsor links

For banner ads click here

STM Week - Innovations Seminar; STM Solutions Seminar; STM Day